Christian Millar

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Molecular Sensing Plc develops software and tools for DNA and RNA analysis. The company is headquartered in Melksham, the United Kingdom.

MTI Partners Ltd (MTI Partners) is an independent venture capital firm founded in 1983. The firm is headquartered in UK.

MP Biomedicals SARL sells and distributes pharmaceutical products and laboratory diagnostic equipment. It offers food supplement, vitamins, minerals, medicines, tubes, purification system, and specimen kit. The company was founded on March 14, 1985 and is headquartered in Illkirch-Graffenstaden, France.

eLabsEurope provides online assistance for sourcing and purchasing laboratory supplies. The private company is based in London, UK.

Hunter-Fleming Ltd. dvelops pharmaceutical products. The company was founded by James R. Murray, John S. Fox and Ernst Wülfert in February 1999 and is headquartered in Brixham, the United Kingdom.

Part of Grupo Start People, Quantum provides quantum technology, software, and services to help organizations make their unstructured data smarter. With over 40 years of innovation, Quantum's platform can orchestrate, protect, and enrich data across its lifecycle, providing enhanced intelligence and actionable insights. Quantum is trusted by leading organizations in cloud services, entertainment, government, research, education, transportation, and enterprise IT. Quantum was acquired by Grupo Start People on April 03, 2001.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK.

IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.

Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom.

Femeda Ltd. develops and manufactures medical devices to treat incontinence. It offers devices for electro stimulation of the pelvic floor and provides a pro-active treatment of bladder leakage. The company was founded by James Bradley and Alison Caroline Kibble in 2002 and is headquartered in Cramlington, the United Kingdom.

Alcolizer Technology United Kingdom Ltd. produces drug testing kits. It offers a device used in detecting whether a person in under the influence of specific drugs. The company was founded by Craig Edward Banks and Richard G. Compton on September 26, 2006 and is headquartered in Gateshead, the United Kingdom.

Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies.

OBS Medical Ltd. manufactures and distributes physiological monitoring and patient monitoring devices. Its product Visensia, a physiological monitoring system for detecting early clinical patient deterioration. The firm operates as a predictive software company that provides products and services for the hospital, community and consumer health care markets. It develops and support products that enable their customers, both patients and healthcare professionals, to manage and monitor health conditions more effectively through simplification, risk identification and prevention. The company was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Marwyn Capital LLP provides financial advisory services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The British company was founded in 2005 by David Jeffreys Williams.

Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. The company has deep relationships with Oxford University and is located on the Oxford Science Park. Celleron is focused on developing new and innovative therapies to treat cancer, with a particular emphasis on clinical development. The British company is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. Celleron's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company was founded in 2004 and is led by CEO Nick la Thangue.

Oxtex Ltd. operates as an early-stage medical device company. It develops novel devices for soft tissue expansion. The firm's technology comprises implantable self-inflating tissue expanders available in sizes and shapes to suit the specific needs of the clinician and the patient. The company was founded by Jan Tadeusz Czernuszka and David Edward Jackson in May 2011 and is headquartered in Witney, the United Kingdom.

Patamar Capital LLC (Patamar Capital) is a venture capital firm founded in 2011 by Chester Tanner Woolley, Lee FitzGerald and Beau T Seil. The firm is headquartered in San Francisco, California.

Kit Trading Fund Ltd. incubates and supports talented trading groups or individuals. The private company is based in Singapore, Singapore.

Liver Group Charity operates as a charity. The private company is based in London, UK.

Global Bionic Optics Ltd. is a private company headquartered in Sydney, Australia, that manufactures optical instruments and lenses.

RYSE Asset Management LLP (RYSE) is a venture capital firm founded in 2010 by Atique Mirza. The firm is headquartered in London, the United Kingdom.

Bio-Techne Ltd. engages in the provision of research and development systems and biotechnology products. The company was founded on April 6, 1990 and is headquartered in Abingdon, the United Kingdom.